$ATOS
ATOSSA THERAPEUTICS, INC. Stock $atos

$atos Overview Financials Valuation SEC Filings Company Website

2019 Q1 Form 10-K Financial Statement

#000143774919005927 Filed on March 28, 2019

Income Statement

Concept	2019 Q1	2017 Q4	2017
Revenue	$0.00	$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$2.610M	$1.330M	$4.860M
YoY Change	86.43%	-7.64%	-25.0%
% of Gross Profit
Research & Development	$1.451M	$220.0K	$2.328M
YoY Change	208.13%	-40.54%	202.35%
% of Gross Profit
Depreciation & Amortization	$13.98K	$30.00K	$129.0K
YoY Change	77.81%	-57.14%	-57.0%
% of Gross Profit
Operating Expenses	$4.064M	$1.550M	$7.649M
YoY Change	116.83%	-13.89%	5.51%
Operating Profit	-$4.064M		-$7.649M
YoY Change	116.83%		5.51%
Interest Expense		$0.00	$0.00
YoY Change			-100.0%
% of Operating Profit
Other Income/Expense, Net	-$8.978K	$20.00K	$154.00
YoY Change	-15316.95%
Pretax Income	-$4.073M	-$1.990M	-$8.123M
YoY Change	117.31%	-21.03%	27.51%
Income Tax			$0.00
% Of Pretax Income
Net Earnings	-$4.073M	-$1.990M	-$8.123M
YoY Change	117.31%	-21.03%	27.51%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share	-$619.5K	-$1.031M	-$8.371M
COMMON SHARES
Basic Shares Outstanding	9.116M
Diluted Shares Outstanding

Balance Sheet

Concept	2019 Q1	2017 Q4	2017
SHORT-TERM ASSETS
Cash & Short-Term Investments	$19.60M	$7.200M	$7.220M
YoY Change	308.33%	140.0%	138.28%
Cash & Equivalents	$19.57M	$7.217M	$7.220M
Short-Term Investments
Other Short-Term Assets	$27.96K	$16.34K	$320.0K
YoY Change	-95.34%	-94.55%	39.13%
Inventory
Prepaid Expenses	$835.5K	$250.9K
Receivables
Other Receivables
Total Short-Term Assets	$20.78M	$7.898M	$7.900M
YoY Change	264.55%	139.33%	143.08%
LONG-TERM ASSETS
Property, Plant & Equipment	$48.21K	$11.47K	$10.00K
YoY Change	-51.79%	-88.53%	-83.33%
Goodwill
YoY Change
Intangibles		$234.0K
YoY Change
Long-Term Investments
YoY Change
Other Assets	$17.22K	$178.9K	$180.0K
YoY Change	-82.78%	-10.55%	-5.26%
Total Long-Term Assets	$245.2K	$266.1K	$260.0K
YoY Change	-18.27%	-66.74%	-70.79%
TOTAL ASSETS
Total Short-Term Assets	$20.78M	$7.898M	$7.900M
Total Long-Term Assets	$245.2K	$266.1K	$260.0K
Total Assets	$21.02M	$8.164M	$8.160M
YoY Change	250.41%	99.12%	97.1%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$464.0K	$334.9K	$330.0K
YoY Change	131.99%	11.63%	32.0%
Accrued Expenses	$74.84K	$90.11K	$870.0K
YoY Change	-85.03%	-88.74%	10.13%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$1.491M	$1.225M	$1.230M
YoY Change	113.02%	22.54%	17.14%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$0.00
YoY Change
Total Long-Term Liabilities	$0.00	$0.00	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.491M	$1.225M	$1.230M
Total Long-Term Liabilities	$0.00	$0.00	$0.00
Total Liabilities	$1.529M	$1.200M	$1.230M
YoY Change	118.36%	20.0%	17.14%
SHAREHOLDERS EQUITY
Retained Earnings	-$80.90M	-$65.43M
YoY Change
Common Stock	$99.70M	$72.37M
YoY Change
Preferred Stock	$702.0K
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$19.50M	$6.939M	$6.940M
YoY Change
Total Liabilities & Shareholders Equity	$21.02M	$8.164M	$8.160M
YoY Change	250.41%	99.12%	97.1%

Cashflow Statement

Concept	2019 Q1	2017 Q4	2017
OPERATING ACTIVITIES
Net Income	-$4.073M	-$1.990M	-$8.123M
YoY Change	117.31%	-21.03%	27.51%
Depreciation, Depletion And Amortization	$13.98K	$30.00K	$129.0K
YoY Change	77.81%	-57.14%	-57.0%
Cash From Operating Activities	-$2.149M	-$1.680M	-$6.594M
YoY Change	-9.97%	24.44%	22.79%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	11.34M	6.160M	10.78M
YoY Change			129.44%
NET CHANGE
Cash From Operating Activities	-2.149M	-1.680M	-6.594M
Cash From Investing Activities
Cash From Financing Activities	11.34M	6.160M	10.78M
Net Change In Cash	9.188M	4.480M	4.190M
YoY Change	-476.86%	-431.85%	-716.1%
FREE CASH FLOW
Cash From Operating Activities	-$2.149M	-$1.680M	-$6.594M
Capital Expenditures
Free Cash Flow	-$2.149M		-$6.594M
YoY Change	-11.85%		23.02%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2018Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	10380493
CY2017Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	7217469
CY2017	atos	Adjustments To Additional Paid In Capital Stock And Warrants Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockAndWarrantsIssuedIssuanceCosts	768412
CY2018	atos	Adjustments To Additional Paid In Capital Stock And Warrants Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockAndWarrantsIssuedIssuanceCosts	1333449
CY2018	atos	Amortization Of Commitment Shares AmortizationOfCommitmentShares	72790
CY2017	atos	Amortization Of Commitment Shares AmortizationOfCommitmentShares	79410
CY2018	atos	Change In Stock Based Compensation Liability ChangeInStockBasedCompensationLiability	1410025
CY2017	atos	Change In Stock Based Compensation Liability ChangeInStockBasedCompensationLiability
CY2017	atos	Class Of Warrant Or Right Exercised ClassOfWarrantOrRightExercised	488611
CY2017	atos	Class Of Warrant Or Right Exercised Exercise Price ClassOfWarrantOrRightExercisedExercisePrice	3.12
CY2017	atos	Class Of Warrant Or Right Granted ClassOfWarrantOrRightGranted	488611
CY2017	atos	Class Of Warrant Or Right Granted Exercise Price ClassOfWarrantOrRightGrantedExercisePrice	11.25
CY2018Q4	atos	Consummate A Business Combination Percentage Of Acquired Outstanding Shares ConsummateABusinessCombinationPercentageOfAcquiredOutstandingShares	0.5
CY2017	atos	Additional Paid In Capital Allocation Of Class Unit Proceeds To Warrant Liability AdditionalPaidInCapitalAllocationOfClassUnitProceedsToWarrantLiability	328350
CY2017	atos	Adjustments To Additional Paid In Capital Preferred Stock Deemed Dividend AdjustmentsToAdditionalPaidInCapitalPreferredStockDeemedDividend
CY2018	atos	Adjustments To Additional Paid In Capital Preferred Stock Deemed Dividend AdjustmentsToAdditionalPaidInCapitalPreferredStockDeemedDividend
CY2018Q4	atos	Consummate A Business Combination Percentage Of Aggregate Ordinary Voting Power ConsummateABusinessCombinationPercentageOfAggregateOrdinaryVotingPower	0.5
CY2018	atos	Effective Income Tax Rate Reconciliation Effect Of Nol Limitation EffectiveIncomeTaxRateReconciliationEffectOfNolLimitation
CY2017	atos	Effective Income Tax Rate Reconciliation Effect Of Nol Limitation EffectiveIncomeTaxRateReconciliationEffectOfNolLimitation	16119293
CY2018	atos	Expiration Dates Of Class Of Warrant Or Right ExpirationDatesOfClassOfWarrantOrRight
CY2018	atos	Increase Decrease In Research And Development Tax Rebate Receivable IncreaseDecreaseInResearchAndDevelopmentTaxRebateReceivable	159821
CY2017	atos	Increase Decrease In Research And Development Tax Rebate Receivable IncreaseDecreaseInResearchAndDevelopmentTaxRebateReceivable	358277
CY2018Q4	atos	Intangible Asset Measurement Input IntangibleAssetMeasurementInput	0.485
CY2017	atos	Issuance Of Common Stock Upon Warrant Exercise For Cash On Liability Warrant Exercise IssuanceOfCommonStockUponWarrantExerciseForCashOnLiabilityWarrantExercise	749233
CY2017Q2	atos	Lockup Period Extension LockupPeriodExtension	P45D
CY2018Q4	atos	Number Of Shares Authorized To Issue NumberOfSharesAuthorizedToIssue	185000000
CY2018Q4	atos	Operating Lease Lessee Monthly Rent Expense OperatingLeaseLesseeMonthlyRentExpense	3660
CY2018Q2	atos	Preferred Stock Deemed Dividend PreferredStockDeemedDividend	11479308
	atos	Preferred Stock Deemed Dividend PreferredStockDeemedDividend	11479308
CY2018	atos	Preferred Stock Deemed Dividend PreferredStockDeemedDividend	11479308
CY2017	atos	Preferred Stock Deemed Dividend PreferredStockDeemedDividend	2568132
CY2018	atos	Proceeds From Issuance Of Common Stock And Warrants ProceedsFromIssuanceOfCommonStockAndWarrants
CY2017	atos	Proceeds From Issuance Of Common Stock And Warrants ProceedsFromIssuanceOfCommonStockAndWarrants	6162588
CY2018	atos	Proceeds From Issuance Of Stock Units ProceedsFromIssuanceOfStockUnits
CY2017	atos	Proceeds From Issuance Of Stock Units ProceedsFromIssuanceOfStockUnits	3871636
CY2018Q4	atos	Professional Services Current ProfessionalServicesCurrent	110094
CY2017Q4	atos	Professional Services Current ProfessionalServicesCurrent	97788
CY2017	atos	Reclassification Of Warrant Liability Upon Exercise Of Common Stock Warrants ReclassificationOfWarrantLiabilityUponExerciseOfCommonStockWarrants	1893160
CY2017	atos	Reduction In Deferred Tax Assets ReductionInDeferredTaxAssets	1900000
CY2018Q4	atos	Research And Development Current ResearchAndDevelopmentCurrent	218090
CY2017Q4	atos	Research And Development Current ResearchAndDevelopmentCurrent
CY2018Q4	atos	Research And Development Tax Rebate Receivable ResearchAndDevelopmentTaxRebateReceivable	518098
CY2017Q4	atos	Research And Development Tax Rebate Receivable ResearchAndDevelopmentTaxRebateReceivable	358277
CY2017	atos	Stock And Warrants Issued During Period Value StockAndWarrantsIssuedDuringPeriodValue	6162588
CY2018	atos	Stock And Warrants Issued During Period Value StockAndWarrantsIssuedDuringPeriodValue	12290551
CY2014Q2	atos	Stockholder Rights Agreement Acquiring Person Additional Percentage Of Ownership StockholderRightsAgreementAcquiringPersonAdditionalPercentageOfOwnership	0.02
CY2014Q2	atos	Stockholder Rights Agreement Acquiring Person Percentage Of Ownership StockholderRightsAgreementAcquiringPersonPercentageOfOwnership	0.15
CY2014Q2	atos	Stockholder Rights Agreement Initial Exercise Price Of Each Right StockholderRightsAgreementInitialExercisePriceOfEachRight	15
CY2014Q2	atos	Stockholder Rights Agreement Number Of Preferred Stock Right Distributed For Each Share Of Common Stock StockholderRightsAgreementNumberOfPreferredStockRightDistributedForEachShareOfCommonStock	1
CY2014Q2	atos	Stockholder Rights Agreement Share Price StockholderRightsAgreementSharePrice	30
CY2018	atos	Warrant Financing Expense WarrantFinancingExpense
CY2017	atos	Warrant Financing Expense WarrantFinancingExpense	192817
CY2018Q4	atos	Warrant Liabilities WarrantLiabilities	0
CY2017Q4	atos	Warrant Liabilities WarrantLiabilities	0
CY2018Q4	atos	Working Capital WorkingCapital	8600000
CY2018	dei	Amendment Flag AmendmentFlag	false
CY2018	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2018	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2018
CY2018	dei	Document Period End Date DocumentPeriodEndDate	2018-12-31
CY2018	dei	Document Type DocumentType	10-K
CY2017	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-10.97
CY2017	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.35
CY2018	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2019Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	9116490
CY2018	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2018Q2	dei	Entity Public Float EntityPublicFloat	4874099
CY2018	dei	Entity Shell Company EntityShellCompany	false
CY2018	dei	Entity Small Business EntitySmallBusiness	true
CY2018	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2018	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2018Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	353328
CY2017Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	334901
CY2018Q4	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	697995
CY2017Q4	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	566000
CY2018Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	177074
CY2017Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	90105
CY2018Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	76335
CY2017Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	71006
CY2018Q4	us-gaap	Accrued Vacation Current AccruedVacationCurrent	160740
CY2017Q4	us-gaap	Accrued Vacation Current AccruedVacationCurrent	147861
CY2018Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	162000
CY2017Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	160000
CY2018Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	82204902
CY2017Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	71887674
CY2018Q4	us-gaap	Additional Paid In Capital Preferred Stock AdditionalPaidInCapitalPreferredStock	2378997
CY2017Q4	us-gaap	Additional Paid In Capital Preferred Stock AdditionalPaidInCapitalPreferredStock
CY2017	us-gaap	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature	-1284066
CY2018	us-gaap	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
CY2017	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	786550
CY2018	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1053496
CY2017	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	267231
CY2018	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1053496
CY2017	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	786550
CY2018	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	29811
CY2017	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	103038
CY2018	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4317405
CY2017	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	375199
CY2018Q4	us-gaap	Assets Assets	11720446
CY2017Q4	us-gaap	Assets Assets	8164094
CY2018Q4	us-gaap	Assets Current AssetsCurrent	11549366
CY2017Q4	us-gaap	Assets Current AssetsCurrent	7898034
CY2017Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	0
CY2018Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2017Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2018Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.18
CY2017Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.18
CY2016Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0
CY2017Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0
CY2017	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	80408
CY2018	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	24405
CY2018Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
CY2018Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	3875699
CY2016Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	0
CY2017Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	7272469
CY2016Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	3082962
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	10490493
CY2018	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	3218024
CY2017	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	4189507
CY2018Q4	us-gaap	Cash Uninsured Amount CashUninsuredAmount	10052914
CY2017Q4	us-gaap	Cash Uninsured Amount CashUninsuredAmount	6967469
CY2018Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	175000000
CY2017Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	175000000
CY2018Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	5846552
CY2017Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2651952
CY2018Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	5846552
CY2017Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2651952
CY2018Q4	us-gaap	Common Stock Value CommonStockValue	1052372
CY2017Q4	us-gaap	Common Stock Value CommonStockValue	477342
CY2017	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	3234773
CY2018Q4	us-gaap	Deferred Compensation Share Based Arrangements Liability Current DeferredCompensationShareBasedArrangementsLiabilityCurrent	1410025
CY2017Q4	us-gaap	Deferred Compensation Share Based Arrangements Liability Current DeferredCompensationShareBasedArrangementsLiabilityCurrent
CY2018Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Subject To Expiration DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration	12300000
CY2018Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Compensated Absences DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences	33755
CY2017Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Compensated Absences DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences	31051
CY2018Q4	us-gaap	Deferred Tax Assets Capital Loss Carryforwards DeferredTaxAssetsCapitalLossCarryforwards	1027111
CY2017Q4	us-gaap	Deferred Tax Assets Capital Loss Carryforwards DeferredTaxAssetsCapitalLossCarryforwards	1027111
CY2018Q4	us-gaap	Deferred Tax Assets Charitable Contribution Carryforwards DeferredTaxAssetsCharitableContributionCarryforwards	707
CY2017Q4	us-gaap	Deferred Tax Assets Charitable Contribution Carryforwards DeferredTaxAssetsCharitableContributionCarryforwards	677
CY2018Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	572687
CY2017Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	634521
CY2018Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	21881
CY2017Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	21881
CY2018Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0
CY2017Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0
CY2018Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	32850
CY2017Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	27554
CY2018Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	2588401
CY2017Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	747589
CY2018Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Bonuses DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBonuses	99666
CY2017Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Bonuses DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBonuses
CY2018Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	968170
CY2017Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	620789
CY2018Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Impairment Losses DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses	33241
CY2017Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Impairment Losses DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses	33241
CY2018Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	5312769
CY2017Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	3089306
CY2018Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	32850
CY2017Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	27554
CY2018Q4	us-gaap	Deposit Assets DepositAssets	16718
CY2017Q4	us-gaap	Deposit Assets DepositAssets	14218
CY2018	us-gaap	Depreciation Depreciation	14386
CY2017	us-gaap	Depreciation Depreciation	25956
CY2018	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	44197
CY2017	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	128994
CY2018	us-gaap	Disposal Group Not Discontinued Operation Gain Loss On Disposal DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
CY2017	us-gaap	Disposal Group Not Discontinued Operation Gain Loss On Disposal DisposalGroupNotDiscontinuedOperationGainLossOnDisposal	-17695
CY2018Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-5.08
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-6.11
CY2018	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-5.50
CY2018	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	0
CY2017	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	461715
CY2018Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	935070
CY2017Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	784867
CY2017	us-gaap	Income Tax Reconciliation Prior Year Income Taxes IncomeTaxReconciliationPriorYearIncomeTaxes	-126031
CY2018	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	18427
CY2017	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	80581
CY2018	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	86969
CY2017	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	73141
CY2018	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	150203
CY2017	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	14968
CY2018	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-74301
CY2018	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants
CY2017	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	280747
CY2018Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	93000
CY2017Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	158000
CY2018Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	99375
CY2017Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	75686
CY2018	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	7224252
CY2017	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4859369
CY2018	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0
CY2017	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0
CY2018	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-11404934
CY2017	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-8122581
CY2018	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0
CY2017	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0
CY2018	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	2223463
CY2017	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-15344015
CY2018	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate
CY2017	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	1912427
CY2018	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-2395036
CY2017	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-2761678
CY2018	us-gaap	Income Tax Reconciliation Nondeductible Expense Other IncomeTaxReconciliationNondeductibleExpenseOther	1616
CY2017	us-gaap	Income Tax Reconciliation Nondeductible Expense Other IncomeTaxReconciliationNondeductibleExpenseOther	2668
CY2018	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	169957
CY2017	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	197336
CY2018	us-gaap	Income Tax Reconciliation Prior Year Income Taxes IncomeTaxReconciliationPriorYearIncomeTaxes
CY2017	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	9451
CY2018	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	258889
CY2017	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	79343
CY2018Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	192000
CY2017Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	234000
CY2018	us-gaap	Interest Paid Net InterestPaidNet
CY2017	us-gaap	Interest Paid Net InterestPaidNet	330
CY2018Q4	us-gaap	Lessee Operating Lease Term Of Contract LesseeOperatingLeaseTermOfContract	P1Y300D
CY2018Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	11720446
CY2017Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	8164094
CY2018Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2915436
CY2017Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1225407
CY2018Q1	us-gaap	Loss Contingency Damages Paid Value LossContingencyDamagesPaidValue	3500000
CY2018	us-gaap	Nature Of Operations NatureOfOperations	<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" margin: 0pt; text-align: justify; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline;"></div>NOTE <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1:</div> NATURE OF OPERATIONS</div></div> <div style=" margin: 0pt; text-align: left; text-indent: 36pt; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </div> <div style=" margin: 0pt; text-align: left; text-indent: 36pt; font-family: "Times New Roman", Times, serif; font-size: 10pt;">Atossa Genetics Inc. (the “Company”) was incorporated on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> April 30, 2009, </div>in the State of Delaware. The Company was initially formed to develop and market medical devices, laboratory tests and therapeutics to address breast health conditions. The Company’s fiscal year ends on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31. </div>The Company is currently focused on development of its pharmaceutical and drug delivery programs for the treatment of breast cancer and other breast conditions.</div></div>
CY2018	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	12290551
CY2017	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	10783457
CY2018	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-110906
CY2017	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities
CY2018	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-8961621
CY2017	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-6593950
CY2018	us-gaap	Net Income Loss NetIncomeLoss	-11404934
CY2017	us-gaap	Net Income Loss NetIncomeLoss	-8122581
CY2018Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-15621885
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-17496267
CY2018	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-22884242
CY2017	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-10690713
CY2018	us-gaap	Operating Expenses OperatingExpenses	11434233
CY2017	us-gaap	Operating Expenses OperatingExpenses	7649171
CY2018	us-gaap	Operating Income Loss OperatingIncomeLoss	-11434233
CY2017	us-gaap	Operating Income Loss OperatingIncomeLoss	-7649171
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	73200
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	43920
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	29280
CY2018	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	31457
CY2017	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	33285
CY2018Q4	us-gaap	Other Assets Current OtherAssetsCurrent	30942
CY2017Q4	us-gaap	Other Assets Current OtherAssetsCurrent	16344
CY2018Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	17218
CY2017Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	178907
CY2018Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	39939
CY2017Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	15534
CY2018	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	29299
CY2017	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	154
CY2018Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	4355
CY2017Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	13882
CY2018	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	110906
CY2017	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment
CY2018Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2017Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2018Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000
CY2017Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000
CY2018Q4	us-gaap	Preferred Stock Value PreferredStockValue	2
CY2017Q4	us-gaap	Preferred Stock Value PreferredStockValue
CY2018Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	509833
CY2017Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	250944
CY2018Q4	us-gaap	Prepaid Insurance PrepaidInsurance	160576
CY2017Q4	us-gaap	Prepaid Insurance PrepaidInsurance	125056
CY2018	us-gaap	Proceeds From Issuance Of Preferred Stock Preference Stock And Warrants ProceedsFromIssuanceOfPreferredStockPreferenceStockAndWarrants	12290551
CY2017	us-gaap	Proceeds From Issuance Of Preferred Stock Preference Stock And Warrants ProceedsFromIssuanceOfPreferredStockPreferenceStockAndWarrants
CY2018	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises
CY2017	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	749233
CY2018Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	216000
CY2017Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	171000
CY2018Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	54487
CY2017Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	11467
CY2018	us-gaap	Reclassifications Reclassifications	<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">NOTE <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15:</div>  RESTATEMENT TO PREVIOUSLY ISSUED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</div></div></div> <div style=" margin: 0pt 22.2pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"> </div></div></div> <div style=" margin: 0pt 14.7pt 0pt 6pt; text-align: left; text-indent: 27pt; font-family: "Times New Roman", Times, serif; font-size: 10pt;">The Company has corrected an inadvertent error in the calculation of the deemed dividend on Series B convertible preferred stock in the financial statements for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">six</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 30, 2018 </div>that were included in the Company’s Form <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10</div>-Q filed on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> August 13, 2018 (</div>the “Original Form <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10</div>-Q”). Accounting principles generally accepted in the United States of America require that we allocate the proceeds from the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> May 2018 </div>financing to the warrants and preferred stock issued in the financing and that we estimate and record any discount on the securities as a deemed dividend. In the financial statements included in the Original Form <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10</div>-Q, we did <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> properly allocate the proceeds to the warrants, and we did <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> properly record the deemed dividend related to the warrant discount as additional paid in capital to common stock. The Company incorrectly stated the deemed dividend for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">six</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 30, 2018 </div>as <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$4,782,100,</div> rather than <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$11,479,308.</div> The corrections result from application of technical accounting rules and do <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> impact cash or operations.</div> <div style=" margin: 0pt 22.2pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </div> <div style=" margin: 0pt 14.7pt 0pt 6pt; text-align: left; text-indent: 27pt; font-family: "Times New Roman", Times, serif; font-size: 10pt;">In accordance with applicable generally accepted accounting principles, the Company has calculated and recognized adjustments accordingly. The following table shows the effect of the restatement on certain line items within the Company’s Condensed Consolidated Statement of Operations for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> months and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">six</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 30, 2018:  </div></div> <div style=" margin: 0pt 22.2pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </div> <div> <table border="0" cellpadding="0" cellspacing="0" style="; text-indent: 0px; font-family: "Times New Roman", Times, serif; font-size: 10pt; min-width: 700px;"> <tr> <td style="width: 44%; vertical-align: bottom;"> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </div> </td> <td style="width: 1%; vertical-align: bottom;"> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </div> </td> <td colspan="6" style="width: 26%; vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">For the Three Months Ended<br /> June 30, 2018</div></div> </td> <td style="width: 1%; vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </div> </td> <td style="width: 1%; vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </div> </td> <td colspan="6" style="width: 26%; vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">For the Six Months Ended<br /> June 30, 2018</div></div> </td> <td style="width: 1%; vertical-align: bottom;"> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </div> </td> </tr> <tr> <td style="width: 44%; vertical-align: bottom;"> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </div> </td> <td style="width: 1%; vertical-align: bottom;"> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </div> </td> <td colspan="2" style="width: 12%; vertical-align: bottom;"> <div style=" margin: 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">Previously</div></div> <div style=" margin: 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">Reported</div></div> </td> <td style="width: 1%; vertical-align: bottom;"> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </div> </td> <td style="width: 1%; vertical-align: bottom;"> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </div> </td> <td colspan="2" style="width: 12%; vertical-align: bottom;"> <div style=" margin: 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">Restated</div></div> </td> <td style="width: 1%; vertical-align: bottom;"> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </div> </td> <td style="width: 1%; vertical-align: bottom;"> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </div> </td> <td colspan="2" style="width: 12%; vertical-align: bottom;"> <div style=" margin: 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">Previously</div></div> <div style=" margin: 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">Reported</div></div> </td> <td style="width: 1%; vertical-align: bottom;"> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </div> </td> <td style="width: 1%; vertical-align: bottom;"> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </div> </td> <td colspan="2" style="width: 12%; vertical-align: bottom;"> <div style=" margin: 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">Restated</div></div> </td> <td style="width: 1%; vertical-align: bottom;"> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </div> </td> </tr> <tr style="background-color: rgb(204, 238, 255);"> <td style="width: 44%; vertical-align: bottom;"> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;">Deemed dividend attributable to preferred stock</div> </td> <td style="width: 1%; vertical-align: bottom;"> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </div> </td> <td style="width: 1%; vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;">$</div> </td> <td style="width: 11%; vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div><div style=" margin: 0pt; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt;">(4,782,100</div> </td> <td style="width: 1%; vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;">)</div> </td> <td style="width: 1%; vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </div> </td> <td style="width: 1%; vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;">$</div> </td> <td style="width: 11%; vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div><div style=" margin: 0pt; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt;">(11,479,308</div> </td> <td style="width: 1%; vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;">)</div> </td> <td style="width: 1%; vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </div> </td> <td style="width: 1%; vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;">$</div> </td> <td style="width: 11%; vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div><div style=" margin: 0pt; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt;">(4,782,100</div> </td> <td style="width: 1%; vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;">)</div> </td> <td style="width: 1%; vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </div> </td> <td style="width: 1%; vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;">$</div> </td> <td style="width: 11%; vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div><div style=" margin: 0pt; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt;">(11,479,308</div> </td> <td style="width: 1%; vertical-align: bottom;"> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;">)</div> </td> </tr> <tr style="background-color: rgb(255, 255, 255);"> <td style="width: 44%; vertical-align: bottom;"> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;">Net loss applicable to common stockholders</div> </td> <td style="width: 1%; vertical-align: bottom;"> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </div> </td> <td style="width: 1%; vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;">$</div> </td> <td style="width: 11%; vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div><div style=" margin: 0pt; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt;">(8,924,677</div> </td> <td style="width: 1%; vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;">)</div> </td> <td style="width: 1%; vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </div> </td> <td style="width: 1%; vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;">$</div> </td> <td style="width: 11%; vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div><div style=" margin: 0pt; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt;">(15,621,885</div> </td> <td style="width: 1%; vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;">)</div> </td> <td style="width: 1%; vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </div> </td> <td style="width: 1%; vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;">$</div> </td> <td style="width: 11%; vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div><div style=" margin: 0pt; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt;">(10,799,059</div> </td> <td style="width: 1%; vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;">)</div> </td> <td style="width: 1%; vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </div> </td> <td style="width: 1%; vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;">$</div> </td> <td style="width: 11%; vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div><div style=" margin: 0pt; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt;">(17,496,267</div> </td> <td style="width: 1%; vertical-align: bottom;"> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;">)</div> </td> </tr> <tr style="background-color: rgb(204, 238, 255);"> <td style="width: 44%; vertical-align: bottom;"> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;">Loss per common share -basic and diluted</div> </td> <td style="width: 1%; vertical-align: bottom;"> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </div> </td> <td style="width: 1%; vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;">$</div> </td> <td style="width: 11%; vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div><div style=" margin: 0pt; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt;">(2.90</div> </td> <td style="width: 1%; vertical-align: bottom;"> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;">)</div> </td> <td style="width: 1%; vertical-align: bottom;"> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </div> </td> <td style="width: 1%; vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;">$</div> </td> <td style="width: 11%; vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div><div style=" margin: 0pt; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt;">(5.08</div> </td> <td style="width: 1%; vertical-align: bottom;"> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;">)</div> </td> <td style="width: 1%; vertical-align: bottom;"> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </div> </td> <td style="width: 1%; vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;">$</div> </td> <td style="width: 11%; vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div><div style=" margin: 0pt; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt;">(3.77</div> </td> <td style="width: 1%; vertical-align: bottom;"> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;">)</div> </td> <td style="width: 1%; vertical-align: bottom;"> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </div> </td> <td style="width: 1%; vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;">$</div> </td> <td style="width: 11%; vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div><div style=" margin: 0pt; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt;">(6.11</div> </td> <td style="width: 1%; vertical-align: bottom;"> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;">)</div> </td> </tr> </table> </div> <div style=" margin: 0pt 22.2pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </div> <div style=" margin: 0pt 14.7pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;">The following table shows the effect of the restatement on certain line items within the Company’s Condensed Consolidated Statement of Stockholders’ Equity for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">six</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 30, 2018:  </div></div> <div style=" margin: 0pt 22.2pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </div> <div> <table border="0" cellpadding="0" cellspacing="0" style="; text-indent: 0px; font-family: "Times New Roman", Times, serif; font-size: 10pt; min-width: 700px;"> <tr> <td style="width: 44%; vertical-align: bottom;"> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </div> </td> <td style="width: 1%; vertical-align: bottom;"> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </div> </td> <td colspan="6" style="width: 26%; vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">Preferred Stock Additional Paid-in Capital</div></div> </td> <td style="width: 1%; vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </div> </td> <td style="width: 1%; vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </div> </td> <td colspan="6" style="width: 26%; vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">Common Stock Additional Paid-in Capital</div></div> </td> <td style="width: 1%; vertical-align: bottom;"> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </div> </td> </tr> <tr> <td style="width: 44%; vertical-align: bottom;"> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </div> </td> <td style="width: 1%; vertical-align: bottom;"> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </div> </td> <td colspan="2" style="width: 12%; vertical-align: bottom;"> <div style=" margin: 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">Previously</div></div> <div style=" margin: 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">Reported</div></div> </td> <td style="width: 1%; vertical-align: bottom;"> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </div> </td> <td style="width: 1%; vertical-align: bottom;"> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </div> </td> <td colspan="2" style="width: 12%; vertical-align: bottom;"> <div style=" margin: 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">Restated</div></div> </td> <td style="width: 1%; vertical-align: bottom;"> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </div> </td> <td style="width: 1%; vertical-align: bottom;"> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </div> </td> <td colspan="2" style="width: 12%; vertical-align: bottom;"> <div style=" margin: 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">Previously</div></div> <div style=" margin: 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">Reported</div></div> </td> <td style="width: 1%; vertical-align: bottom;"> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </div> </td> <td style="width: 1%; vertical-align: bottom;"> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </div> </td> <td colspan="2" style="width: 12%; vertical-align: bottom;"> <div style=" margin: 0pt; text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">Restated</div></div> </td> <td style="width: 1%; vertical-align: bottom;"> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </div> </td> </tr> <tr style="background-color: rgb(204, 238, 255);"> <td style="width: 44%; vertical-align: bottom;"> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;">Issuance of Series B convertible preferred stock, net of issuance costs</div> </td> <td style="width: 1%; vertical-align: bottom;"> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </div> </td> <td style="width: 1%; vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;">$</div> </td> <td style="width: 11%; vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div><div style=" margin: 0pt; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt;">12,290,537</div> </td> <td style="width: 1%; vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </div> </td> <td style="width: 1%; vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </div> </td> <td style="width: 1%; vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;">$</div> </td> <td style="width: 11%; vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div><div style=" margin: 0pt; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt;">6,926,778</div> </td> <td style="width: 1%; vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </div> </td> <td style="width: 1%; vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </div> </td> <td style="width: 1%; vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;">$</div> </td> <td style="width: 11%; vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div><div style=" margin: 0pt; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt;">0</div> </td> <td style="width: 1%; vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </div> </td> <td style="width: 1%; vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </div> </td> <td style="width: 1%; vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;">$</div> </td> <td style="width: 11%; vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div><div style=" margin: 0pt; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt;">5,363,759</div> </td> <td style="width: 1%; vertical-align: bottom;"> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </div> </td> </tr> <tr style="background-color: rgb(255, 255, 255);"> <td style="width: 44%; vertical-align: bottom;"> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;">Deemed Dividend on Series B convertible preferred stock</div> </td> <td style="width: 1%; vertical-align: bottom;"> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </div> </td> <td style="width: 1%; vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;">$</div> </td> <td style="width: 11%; vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div><div style=" margin: 0pt; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt;">4,782,100</div> </td> <td style="width: 1%; vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </div> </td> <td style="width: 1%; vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </div> </td> <td style="width: 1%; vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;">$</div> </td> <td style="width: 11%; vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div><div style=" margin: 0pt; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt;">11,479,308</div> </td> <td style="width: 1%; vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </div> </td> <td style="width: 1%; vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </div> </td> <td style="width: 1%; vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;">$</div> </td> <td style="width: 11%; vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div><div style=" margin: 0pt; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt;">(4,782,100</div> </td> <td style="width: 1%; vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;">)</div> </td> <td style="width: 1%; vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </div> </td> <td style="width: 1%; vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;">$</div> </td> <td style="width: 11%; vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div><div style=" margin: 0pt; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt;">(11,479,308</div> </td> <td style="width: 1%; vertical-align: bottom;"> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;">)</div> </td> </tr> <tr style="background-color: rgb(204, 238, 255);"> <td style="width: 44%; vertical-align: bottom;"> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;">Conversion of Series B convertible preferred stock to common stock</div> </td> <td style="width: 1%; vertical-align: bottom;"> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </div> </td> <td style="width: 1%; vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;">$</div> </td> <td style="width: 11%; vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div><div style=" margin: 0pt; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt;">(7,056,421</div> </td> <td style="width: 1%; vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;">)</div> </td> <td style="width: 1%; vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </div> </td> <td style="width: 1%; vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;">$</div> </td> <td style="width: 11%; vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div><div style=" margin: 0pt; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt;">(7,821,992</div> </td> <td style="width: 1%; vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;">)</div> </td> <td style="width: 1%; vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </div> </td> <td style="width: 1%; vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;">$</div> </td> <td style="width: 11%; vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div><div style=" margin: 0pt; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt;">6,656,442</div> </td> <td style="width: 1%; vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </div> </td> <td style="width: 1%; vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </div> </td> <td style="width: 1%; vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;">$</div> </td> <td style="width: 11%; vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div><div style=" margin: 0pt; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt;">7,422,013</div> </td> <td style="width: 1%; vertical-align: bottom;"> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </div> </td> </tr> </table> </div></div>
CY2018	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4209981
CY2017	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2328087
CY2018Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	110000
CY2017Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	55000
CY2018Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	110000
CY2017Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	55000
CY2018Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-76831263
CY2017Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-65426329
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2017Q2	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	125000
CY2017	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
CY2018	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
CY2018	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	1053496
CY2017	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	786550
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	8805010
CY2017Q4	us-gaap	Stockholders Equity StockholdersEquity	6938687
CY2016Q4	us-gaap	Stockholders Equity StockholdersEquity	3097106
CY2018	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P10Y
CY2018Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0
CY2017Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0
CY2018Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0
CY2017Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0
CY2018	us-gaap	Use Of Estimates UseOfEstimates	<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" margin: 0pt; text-align: left; text-indent: 36pt; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">Use of Estimates:</div></div> <div style=" margin: 0pt; text-align: left; text-indent: 36pt; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </div> <div style=" margin: 0pt; text-align: left; text-indent: 36pt; font-family: "Times New Roman", Times, serif; font-size: 10pt;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates.</div></div></div></div></div>
CY2018	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	2200000
CY2017	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	-15500000
CY2018	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	4157746
CY2017	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	974773

Files In Submission

Name	View Source	Status
0001437749-19-005927-index-headers.html	Edgar Link	pending
0001437749-19-005927-index.html	Edgar Link	pending
0001437749-19-005927.txt	Edgar Link	pending
0001437749-19-005927-xbrl.zip	Edgar Link	pending
atos-20181231.xml	Edgar Link	completed
atos-20181231.xsd	Edgar Link	pending
atos-20181231_cal.xml	Edgar Link	unprocessable
atos-20181231_def.xml	Edgar Link	unprocessable
atos-20181231_lab.xml	Edgar Link	unprocessable
atos-20181231_pre.xml	Edgar Link	unprocessable
atos20181231_10k.htm	Edgar Link	pending
ex_135719.htm	Edgar Link	pending
ex_135720.htm	Edgar Link	pending
ex_135721.htm	Edgar Link	pending
ex_135722.htm	Edgar Link	pending
ex_135723.htm	Edgar Link	pending
ex_135724.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ATOS
ATOSSA THERAPEUTICS, INC. Stock $atos

2019 Q1 Form 10-K Financial Statement

#000143774919005927 Filed on March 28, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ATOS ATOSSA THERAPEUTICS, INC. Stock $atos

2019 Q1 Form 10-K Financial Statement

#000143774919005927 Filed on March 28, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ATOS
ATOSSA THERAPEUTICS, INC. Stock $atos